UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept

Article

Abstract: Pancreatic ductal adenocarcinoma is an aggressive form of pancreatic cancer and the fourth leading c

Palabras claves:

Autores:

Borrero-Palacios A., Cebrián A., Celdrán A., Fernández-Aceñero M.J., Garcia-Foncillas J., Gebauer F., Georgiev-Hristov T., Gómez del Pulgar M.T., INDACOCHEA A., Li W., Martinez-Useros J., Pérez N., Puerto-Nevado L.d., Puime-Otin A., Rodríguez-Remírez M., Santiago Xavier Guerrero

Fuentes:

google

scopus